Investing.com - Pfizer (NYSE:PFE) reported on Tuesday fourth quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Pfizer announced earnings per share of $1.08 on revenue of $23.84B. Analysts polled by Investing.com anticipated EPS of $0.8742 on revenue of $24.16B.
Pfizer shares are down 9% from the beginning of the year, still down 13.77% from its 52 week high of $61.71 set on December 20, 2021. They are under-performing the S&P 500 which is down 5.92% from the start of the year.
Pfizer follows other major Healthcare sector earnings this month
Pfizer's report follows an earnings beat by UnitedHealth on January 19, who reported EPS of $4.48 on revenue of $73.74B, compared to forecasts EPS of $4.3 on revenue of $72.98B.
J&J had beat expectations on January 25 with fourth quarter EPS of $2.13 on revenue of $24.8B, compared to forecast for EPS of $2.12 on revenue of $25.28B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar